PRD10: COST-EFFECTIVENESS OF AZITHROMYCIN AND CO-AMOXICLAV IN ACUTE SINUSITIS
نویسندگان
چکیده
منابع مشابه
Comparison of cefuroxime and co-amoxiclav in the treatment of acute sinusitis in a sample of the Iranian population.
OBJECTIVES Acute sinusitis is a common upper respiratory tract infection worldwide, which can be severely complicated if inappropriate treatment is applied. The aim of this study was to assess and compare efficacy of cefuroxime and co-amoxiclav in the treatment of acute sinusitis in an Iranian sample population. METHODS A randomized clinical trial, comparing the efficacy of two oral antibioti...
متن کاملCo-amoxiclav in recurrent acute otitis media: placebo controlled study.
OBJECTIVE To determine the efficacy of coamoxiclav in children aged 6 months to 12 years with recurrent acute otitis media. DESIGN A randomised double blind placebo controlled clinical trial. SETTING General practice in the Netherlands. PATIENTS 121 children with recurrent acute otitis media, defined by onset of otalgia and otoscopic signs of middle ear infection within four to 52 weeks a...
متن کاملcost benefits of rehabilitation after acute coronary syndrome in iran; using an epidemiological model
چکیده ندارد.
مقایسه اثر درمان آزیترومایسین، آموکسی سیلین و کو- آموکسی کلاو در درمان کودکان مبتلا به سینوزیت باکتریایی حاد: یک مطالعه کارآزمایی بالینی تصادفی شده
Background and purpose: Acute bacterial sinusitis is a very common disease among children. Empirical therapy for acute bacterial sinusitis often includes a 10-14-day period of β-lactamase. Azithromycin, a sustained high tissue level macrolide, due to its pharmacokinetic profile can be used once daily in a shorter treatment course of 3 to 5 days. This study aimed to compare azithromycin and comm...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Value in Health
سال: 1999
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(11)70957-3